Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Children's Motrin bulletin

This article was originally published in The Tan Sheet

Executive Summary

Children's Motrin bulletin: The American Pharmaceutical Association releases a New Product Bulletin, supported by a grant from McNeil, addressing the pharmacokinetics, dosage, administration, efficacy, adverse effects and precautions associated with Children's Motrin. The bulletin has been circulated to 100,000 pharmacists nationwide. It includes instructions for using the oral liquid syringe needed for administering the product. While Children's Motrin in liquid form was approved for OTC marketing June 16, 1995, applications for approval of the product in chewable tablet and caplet form are still pending at FDA ("The Tan Sheet" June 26, 1995, p.5)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel